Review of All Solid Tumor Drug Approvals From 2019 to 2024 by US Food and Drug Administration, European Medicines Agency, and Brazilian Health Regulatory Agency
PURPOSERegulatory agencies play a pivotal role in evaluating clinical evidence for oncology drug approvals. This study aimed to compare approved indications across the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Brazilian Health Regulatory Agency (ANVISA), with a focu...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society of Clinical Oncology
2025-10-01
|
| coleção: | JCO Global Oncology |
| Acesso em linha: | https://ascopubs.org/doi/10.1200/GO-25-00326 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|